• objective: aimed to compare laparoscopic/robot-assisted hysteropexy with vaginal hysterectomy for uterine prolapse

• prospective randomized clinical trial

• patient

  1. 60yrs or more women and
  2. POP-Q stage II with symptom or POP-Q III, IV regardless of symptom

• number of patient: 146

• randomize: laparoscopic/robot-assisted hysteropexy vs. hysterectomy

• follow up: postoperative 1 year

• primary endpoint: recurrence rate

  1. recurrence of uterovaginal prolapse POP-Q stage II-IV
  2. recurrence of associated symptom

• secondary endpoint

  1. postoperative 1 year QOL, degree of satisfaction evaluation
  2. operative time, estimated blood loss
  3. hospitalization period, postoperative pain, return to normal activity

Inclusion Criteria:

• POP-Q stage II with symptom or POP-Q III, IV regardless of symptom

Exclusion Criteria:

• abnormal uterine bleeding
• significantly enlarged fibroid uterus
• postmenopausal uterine bleeding
• endometrial pathology
• on tamexifen
• concomitant medical problems precluding general anesthesia or surgery
• damaged agreement ability